Clinical Trials Directory

Trials / Sponsors / LaNova Medicines Limited

LaNova Medicines Limited

Industry · 15 registered clinical trials — 9 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingLM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Pos
Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
Phase 32026-04-03
RecruitingPhase II Study of LM-24C5
Advanced Solid Tumor Cancer
Phase 22025-12-15
RecruitingA Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours
Advanced Solid Tumor
Phase 1 / Phase 22025-09-17
RecruitingA Study of LM-350 in Subjects With Advanced Solid Tumours
Malignant Tumors
Phase 1 / Phase 22025-08-28
RecruitingA Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours
Advanced Solid Tumours
Phase 1 / Phase 22025-05-06
Not Yet RecruitingA Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours
Advanced Solid Tumor
Phase 22025-03-26
RecruitingStudy of LM-299 in Subjects Advanced Malignant Tumors
Malignant Tumors
Phase 1 / Phase 22024-10-09
RecruitingA Study of LM-24C5 For Advanced Solid Tumors
Advanced Solid Tumor
Phase 1 / Phase 22023-12-20
WithdrawnStudy of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell Diseases
Relapsed or Refractory Multiple Myeloma, Other Plasma Cell Diseases
Phase 1 / Phase 22023-01-18
RecruitingA Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
Malignant Tumors
Phase 1 / Phase 22023-01-11
Active Not RecruitingA Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tu
Advanced Solid Tumor
Phase 1 / Phase 22022-08-26
TerminatedStudy of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours
Advanced Solid Tumor
Phase 1 / Phase 22022-05-26
TerminatedStudy of LM-102 in Subjects in Advanced Tumors
Advanced Solid Tumors
Phase 12021-05-27
TerminatedA Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours
Advanced Tumours
Phase 1 / Phase 22021-05-20
TerminatedStudy of LM-061 in Subjects in Advanced Tumors
Advanced Tumours
Phase 12021-05-06